Aggregated real-time headlines, trending Google search queries, and verified dispatches in one single page.
<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTFBya3ZsOE1WbkJOTE5OdEU0TDY1WWNRYXNjaUJaNzFmdUFDYmJRdEdGd1JnYU1EdWc1ZUF6dnZRaC1mM0g1dkhBWXhPd1FwYlR2VVdkOHVMZlNUcTdhWktr?oc=5" target="_blank">A novel CD7-directed antibody-drug conjugate targeting BCL-XL with potent anti-leukemic activity in T-cell acute lymphoblastic leukemia</a>&nbsp;&nbsp;<font color="#6f6f6f">Nature</font>
Bears DE Montez Sweat suspended 2 days for drug violation
Daily Wire's 'Confession': Details Revealed For James Franco, Rob Lowe Film
Bengals tight end Tanner Hudson out for season with torn pec
The top reason to watch every NHL team in the Frozen Frenzy
Updated every 3 minutes via FreeNewsApi, GNews, Currents API & Google News
<a href="https://news.google.com/rss/articles/CBMijgFBVV95cUxQZDl6dzZ5bmE0SVBUWDRsZ2hTbEttZ2VXQU82bWtzQTVEUGpTQ1poWXdLejJaTFBPaU56Qm9FdGZWYWFlY09MaTJnYmRWekdHVVZnSnp1UHBCVE54T3NyeVA2M1dhSjdTZUloSjBtc01NQjRJWmpONVVYenpOUDlaR1VjOEFaZkhSSWZWdGdn?oc=5" target="_blank">Enliven Therapeutics’ leukemia drug shows promise in new study</a>&nbsp;&nbsp;<font color="#6f6f6f">STAT</font>
<a href="https://news.google.com/rss/articles/CBMi9wFBVV95cUxNYUtUT3phUVJKSGlmblhEN2VOeTNFME95YS12RkxUdkRPa0RIUzFtc0pqV0dVSVhIRUs5TEo1VDAxVjJtU0JxUzRZMXFBQlo0b0VIWjJ2NXp5ZzRyU054ZllRZlpmWG11MXJVcWFxRko3RjRYbzZrY1JGODRUQk9XY0lWUGtCSWdMSzlnNDJ2dzFkVjF6YVJWU3hVNmczcVZZVl9PZjU4ekpEWUNaSFVydkJZelJGZGtlQ1B6QlFVWXpTdXFUQkpwZmw4UFBaOTBwejdKMXBQUUdZbWNkaDluME8wX3pFQmpSVndTbTlUamlrYUpycnFZ?oc=5" target="_blank">MBNL1 was identified as a potential cancer drug target for a type of childhood leukemia</a>&nbsp;&nbsp;<font color="#6f6f6f">St. Jude Children's Research Hospital</font>
<a href="https://news.google.com/rss/articles/CBMipgFBVV95cUxQdzU5WDhLZFpwLUk3VnVub3hIdjM1UEZTaTk5Y09wVnF6Ui1GZ0FwYXFMR016NzNMUXVsVUItcEVJbzdpcVFOTTNpUGJ3VUg4UFhYdG9fNnA4REE2SlZQajdMU01JRE5udUNnRWloRGZDc0FOalB3QkkzeG50aDBFQXJLU19pLUxGT3JfNHNsMENBUWMydjNVNFNxbEJiaE5ybXdhNk5n?oc=5" target="_blank">Terns drug shows potential to challenge Novartis’ blockbuster leukemia treatment</a>&nbsp;&nbsp;<font color="#6f6f6f">BioPharma Dive</font>
<a href="https://news.google.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?oc=5" target="_blank">Orum Therapeutics Presents New Preclinical Data at AACR 2026 on ORM-1153, a CD123-Targeting Degrader-Antibody Conjugate, Highlighting Broad Activity in Acute Myeloid Leukemia and the Potential for Improved Efficacy and Tolerability</a>&nbsp;&nbsp;<font color="#6f6f6f">BioSpace</font>
<a href="https://news.google.com/rss/articles/CBMikgFBVV95cUxPczdZSjZ0MDFsMEg2SHFrVVF3UVYyTnE2UTNrZmtfSzQ4NDZCdWsyWUtlazB6VlBiYnRqdXdPUjB1ejBOeTdFR3FqcFdrUy1XQ0tRckk4NkN4dmNQc3FOQ3RrWWdWMHR5LUZaTDl5Z1BySkJjLUI0b1Zvb3VmX08wRkxNdjdnand6ZTRLSTZTd3hXdw?oc=5" target="_blank">ASH 2025: MSD’s B-ALL drug shows potential, but all patients experience AEs</a>&nbsp;&nbsp;<font color="#6f6f6f">Clinical Trials Arena</font>
<a href="https://news.google.com/rss/articles/CBMitAFBVV95cUxOU3B2WEZiT3p2aWIzcDhMRmpnSFFMTXNlYnEwUUcxWE5kb1Y0VzJTdjFIWkR5V0FYdXBUMTdJYjRydnJXTW1STnRaUzNQc2wwSFBwZmhvT1hFVHJVTi0zVjRXM0s2WW5leXhLbHRuMFl4MTZTYkM1elBJNHVDY0JpZVUyR1pXLU5ITDcwRDAtbkUydUc0eXRneV9tTUpmVGpKS0E0Y0hVWjJNVVFkRVJIcWRnd1E?oc=5" target="_blank">Leukemia Drug Shows Potential Against Metastatic HER2-Positive Breast Cancer</a>&nbsp;&nbsp;<font color="#6f6f6f">Duke Health</font>
<a href="https://news.google.com/rss/articles/CBMikwFBVV95cUxQRWR0TWE1NzMwSTVuZnhmZE5HU2RON1IzTG5VRnBTWlNOcmZuc0pYUnhQLWt5SEdHXzVXZWpXT3pzUVNITlowaHBOcnBYUjBFbWpVMWFrTkpMZFQ5VVZiWGxFbGJQRlRJbXBmVm1Lc0lJS2RsMzBsQVREb19Mc1p2Y1RyMWNFNVVnMGg2M3hXWTRXYlk?oc=5" target="_blank">CS18: New Drug Shows Potential to Overcome Cancer Drug Resistance</a>&nbsp;&nbsp;<font color="#6f6f6f">Bioengineer.org</font>
<a href="https://news.google.com/rss/articles/CBMirAFBVV95cUxPeGxDMjRKZTg1NlpROFNvS1RKYU5xdllHNTVoRGYxQWEzamlhZWc2OWhtbmg0NWNQclJ1dmdVdC1iTlJtRjFhczI5LWduVXFNNmpONUtrbzhkTGxfT181THo5S0hJVWR5R3Z4am9xUWdtUzZIcVR0TzFOcGVCNDVVQkdKU1hUcE5Fci1PODViRnF3R1FiLXJGZGw5YU1tV2tmY1d2UHc4WmU2bG1W?oc=5" target="_blank">Leukemia Drug Shows Potential Against Metastatic HER2-Positive Breast Cancer</a>&nbsp;&nbsp;<font color="#6f6f6f">Duke School of Medicine</font>
<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTFBITHdhdmFxdFZKTFBYekZ4ajZ0THctTE0wTUdHbVFfMU95YUNNUFEzVU1VaVpITWJRdTJ5OFhXYWpBN1hwYjJNWnlkaE5Ma1lYWG5HT3FRdHVOb2xLaDR3?oc=5" target="_blank">The Human T-cell Leukemia Virus capsid protein is a potential drug target</a>&nbsp;&nbsp;<font color="#6f6f6f">Nature</font>
<a href="https://news.google.com/rss/articles/CBMikgFBVV95cUxOb0xIc1ZwZEFOMldjMmU5am9jWGFiWS1XUFhmUXNRbGlaRkN2bElZY19qU09idHJDVkJyVzJTeUJQRVFEMHRublJ0X0E5cUpFX3R5UXhKdXNvd0REWmNISVZJV0kwQks2Y3FKX21kMGNHYUEwU3BZNlZjZzNTVHlJdEVlbEZseTQzRzVZUm5aalJjUQ?oc=5" target="_blank">Exosomal biomarkers in leukemia: translational potential and regulatory challenges for precision medicine applications</a>&nbsp;&nbsp;<font color="#6f6f6f">Frontiers</font>
<a href="https://news.google.com/rss/articles/CBMigwFBVV95cUxPd3VpajEyRXJzeUhSUkwwXzV4cEdYMmhWaXY0Q0hqMWZzZERWckEyVXZ5UnRvMkZIb3loem92cmJpa2FhRmFlNkVhVHZfZTB5OFpzYTFtdWpJak1XdFZoVkVzMEUwZ2dhOURKbWJ1WEtjWC1aR1l4SGxFdktiWDhHVGJLUQ?oc=5" target="_blank">Results in Terns leukemia drug study suggest it could be a successor to Novartis blockbuster</a>&nbsp;&nbsp;<font color="#6f6f6f">STAT</font>
<a href="https://news.google.com/rss/articles/CBMizAFBVV95cUxQMFlPSjR0eFNqbE96UGs3dm9tOHRQTUpQZ1pNOXZQdnlFMVJfM3VHaEJ3WGNsemJkN2ttdnFQM1ZxUUlNbkgzSTZZZXBNQ0o0dVgyUi1OdU84aXNCOGctbHA4cEh4N1RxMGdMQV9BM0s1LWNpSUh4ajlzQU5ocDhDalJDQ0FGSWcweE8tRGdCdXZxbHh6ZmY3bUM2cHdwLXd2WklNSFZkSmlONE9OMFpNeHl3aEp1OWUzNC14b2QwOGFpdjhNX2RZV0NaRko?oc=5" target="_blank">Lilly's blood cancer drug shows promise in trial as early treatment</a>&nbsp;&nbsp;<font color="#6f6f6f">Reuters</font>
<a href="https://news.google.com/rss/articles/CBMijwFBVV95cUxQWmg1OHhJRXhhZzNhV2xCVXIxakk1Q0ZWMnF0bXBkQkVhSkVXbzZleXlDb2dxUnoyVW0tZThUb0NaY3FxUGJIMWpSclBfNHY5dHRsbHc4RUVwQzhEMVFsYmNpc1Nma1FoaU54OHktQXlwT3hndXphVUszeTZwMnVJRjRrMzd3TEF3LVZBV2Npdw?oc=5" target="_blank">Leukemia Drug Shows Promise in Rare Ovarian Cancer Type</a>&nbsp;&nbsp;<font color="#6f6f6f">Cure Today</font>
<a href="https://news.google.com/rss/articles/CBMinAFBVV95cUxQOU5SczdrSWNVM2w4MTJ6V0F0T0hUY0ZEUi1BOW1EVWlzakdkUmo1UDlIVFdfRVczNGlXOUNoQkNoY1hhNjhUbXJ2Z3dKbV81bVhPMkpzY3N4djZCcnhqZTA0LVVFdE5fdnlqdHdONHVNR0V0YWJ6aTdTZ1VoZ3N2bVNJSm43bldHb1ZiVDA1QV9QUlpPYTZReVVpZUc?oc=5" target="_blank">Inotuzumab Ozogamicin Shows MRD Clearance in B-Cell ALL Trial</a>&nbsp;&nbsp;<font color="#6f6f6f">CancerNetwork</font>
<a href="https://news.google.com/rss/articles/CBMilAFBVV95cUxOQkE2NXA4S0pob3FaQVc1Uk1kSDBJSlgwRVBnUzQwTWRNeGxLOXoydnNkaFhUTzdzbklGNTdpaGYtOEVRU2czWjh1c0doQjVxd3NMQ2h1bElUYl9Kallsc3c0WHo4dXZxYkNvanZGSkphLVo3OEFPUW1HdmZKUE9aUFlqR0N3MXVmeWxGMzQ2bHZSX2k2?oc=5" target="_blank">CAR T cell therapy leads to 10-year remissions in B-cell lymphoma patients</a>&nbsp;&nbsp;<font color="#6f6f6f">Penn Medicine</font>
<a href="https://news.google.com/rss/articles/CBMizgFBVV95cUxPNDFFc0lfUDk0eGRaTWhvdU5qZndMYk13QjBFY3VEY2hETFZtNDRxMGlLazRUd08xVlM4cERQSFNZcWZ2SEQxSUxNaWhDR1phWko3ZnY1QXRYNzBNMktwUEtLaWV0Znl1ZHc2aVNWVUVNOUlwV0x5MlpfNFFqYXN1WERabWw5Zzg2ZWpiQnNsNE9WZ1Jqa0cyTVhvZGxnUDBQdVVWRzZjTzV4cW9wTlBiU010U3I5eUo2Y2VzTm90Y0pjNlFZUFhRQnRuRzFHZw?oc=5" target="_blank">Blood pressure drug could make leukemia more responsive to chemotherapy</a>&nbsp;&nbsp;<font color="#6f6f6f">Cardiovascular Business</font>
<a href="https://news.google.com/rss/articles/CBMiiwFBVV95cUxQLUUwM1hQVnNVYnNkcHNmb3ZQOV9hUG5zTTBVaU5fVTdVeW1LSkdScVdPTHlUSGg5UnZBaXlpRXctY3czMGlEQ2o5MzQ0YWl5OWZPWTFMWUFraW1kN3diWHM2VW9XZFRpeDJRWXI3ZnoyV2M5X19QR2V1cXRJbzNXdVEtd1NaMDNydDdF?oc=5" target="_blank">From No Hope to a Potential Cure for a Deadly Blood Cancer (Published 2025)</a>&nbsp;&nbsp;<font color="#6f6f6f">The New York Times</font>
<a href="https://news.google.com/rss/articles/CBMinwFBVV95cUxPLWZoYlpFWHd6UUFLWm1fVE5MMEI4dXcwTlZsNDFOSC1PdW1yQTVkU1E3VDBSeC1Qd2xoTUY2dmJuLVFIbHpzc1UyWFhuTU1wNTl4UG9FOHpYQTZPeW1vb1BFcWVjLXFKc25qYmFKRWhqUExxbzVSaXJaSkdFTzZNM2RkVVBrSFlaSnhYVWFsMzl5RGE2V2RaaElFT1c3dUU?oc=5" target="_blank">Ligufalimab Gains FDA Orphan Drug Status for Acute Myeloid Leukemia</a>&nbsp;&nbsp;<font color="#6f6f6f">Cure Today</font>
<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE1Ka1E3bXdmYjZidWVVVTdfR2F3b0tNaG1kWkRHcU8wQktNWmg1Q193dVNWdXFwQ3YyT2o2QzRPOFVQcjhNZU1kRDBVTXNuUkthZHQ0MzM4dWZoY0JfY2tV?oc=5" target="_blank">Mendelian randomization of immune cell phenotypes to discover potential drug targets for B-cell malignancy</a>&nbsp;&nbsp;<font color="#6f6f6f">Nature</font>
<a href="https://news.google.com/rss/articles/CBMiW0FVX3lxTE5uMmNnVjRrSGdHa3h0UW5XTmEzSWlqWldmVGtVNmhTN2hEeF9OQ2xQZW1uMVpwNk9HYnJOa214M2FlYmJRdnNDRTRSQks0R1djaHhvcHNVZHdBc2M?oc=5" target="_blank">Leukemia drug shows the potential to treat aggressive pediatric brain câncer</a>&nbsp;&nbsp;<font color="#6f6f6f">EurekAlert! Science News Releases</font>
<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTFBVUkVObUsxdEpsdHVaRmU2U2FxbzlQZzVNZDN6NnVqQlVGOHlVUDFhbHV1UURIUW5xR0VhUlMyQldZVnBZeFVjZVRYV2dvelEtY1JmVDNvLUNiWFF4Y0J3?oc=5" target="_blank">Effective eradication of acute myeloid leukemia stem cells with FLT3-directed antibody-drug conjugates</a>&nbsp;&nbsp;<font color="#6f6f6f">Nature</font>
<a href="https://news.google.com/rss/articles/CBMijgFBVV95cUxOcU9PWXJUZjkwd201LVBWc09zTTJuNXo1cUtRYkVFZnNPY2NUSmtFYXhzeEo0MV82eWF2Wlk0SVZBNDFWUS0wX29hYzBFWWxVaDJVWnVjOG5TZzl6dzFxazFqR1Z3UWtfSXpLcE1VZFRXQjVjcU5yaGNmYTJZY0ZwZmdzN2VhdDVnay1NdHVB?oc=5" target="_blank">City of Hope Research Spotlight, August 2025</a>&nbsp;&nbsp;<font color="#6f6f6f">City of Hope</font>
<a href="https://news.google.com/rss/articles/CBMiqgFBVV95cUxOd3l0ZDd3ZV9lX1lZdTFVdUloSWI1YlVWT3pLemdJYkx6ZU1NdE9BelFyRGdhYWNIT3ZMb3VSSGhibVEwQlJfUXdfY3hJZ3RJWEtxVUlBblAzQTIxeDlPMWljaDhVeWVqanZUT29ob2FqSWFwaVFVUHAwdW9hdFZOa3ZHQ25hWUswVHdGOHJwRWZRRzJNSkJLblNkMVJFS1R2Sk1pQ25UUlJrQQ?oc=5" target="_blank">Clinical Trial Corner: New Treatments in Leukemia, Lymphoma and Brain Cancers</a>&nbsp;&nbsp;<font color="#6f6f6f">Cure Today</font>
<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE9DcS1iSmpNRTFmYW16SU1xVGxGZllIcnVMUEtMbVE4WGpTNmpUeHJrVlRoMDF0TlgtWVhOdElsZ25Hd2N6WEZRUmdQeXRvZmpIbXQyQVRWWU1yUmpZSFQ4?oc=5" target="_blank">A new TROP2-targeting antibody-drug conjugate shows potent antitumor efficacy in breast and lung cancers</a>&nbsp;&nbsp;<font color="#6f6f6f">Nature</font>
<a href="https://news.google.com/rss/articles/CBMilAFBVV95cUxPcjdRSWJpR2M3TWM4UVc0dDFnV2JaNWliSkh5NnpCenVRdmh3dzZMVUdqMUNCNDRoWTJSZDZ2YnJ5U0c3YjZycjctMl9rTkc3SU9NTThUSVYzMy16Mkg3STdzeE5OQnVOMkdPQ3lIbkxBQkpWTGQ2V0xHQU9qUUh2UnBfUUpURHZNbk1LVm5LbG5tc1I0?oc=5" target="_blank">Epigenetic mechanisms of drug resistance in acute myeloid leukemia: advances in small-molecule targeted therapy</a>&nbsp;&nbsp;<font color="#6f6f6f">Frontiers</font>
<a href="https://news.google.com/rss/articles/CBMiugFBVV95cUxNUnZWRzgzaGpiQkxfOHo0LXQ0aWZkVjZGa1pyRXdUdjF3cDR1VVhSWWJEMkdaRk16ZUQtY2pEbHJYb1pSUFI5ckF1RFFVdlJwcXgzWmJvR1ZJdF9aZDVHdDRtWk40V1ZnMXh6QjJUbXQ4TGs0TWFsbnFMeTZNSEFZdEZNMmY5YUtfS1RZajNPOEFnX3FZSHZGZXAtVTRwdDg3T0RBTWtVcjViRnA2R0JNdzdtRW5TSF9JN1E?oc=5" target="_blank">FDA adcomm takes down Secura Bio's leukemia drug after final trial results show potential OS detriment</a>&nbsp;&nbsp;<font color="#6f6f6f">Endpoints News</font>
<a href="https://news.google.com/rss/articles/CBMihgFBVV95cUxOXzZCeGdqN3hKdExLamI2LWVaNUhyeG84SXd3RGZRSExhc0F3RkctbkkzVkI5T211a1dtUEZFZ0llQ3dycVN3TEVFQnY4SEtLTlRkaE9veUhUbDdDQlItXzBsa2VZb0VZSlVfbG9vSGVFcHA3VjFteE52Umo1V0oybjdCbENLQQ?oc=5" target="_blank">Common blood pressure drug may make leukemia more responsive to chemotherapy while protecting heart</a>&nbsp;&nbsp;<font color="#6f6f6f">Medical Xpress</font>
<a href="https://news.google.com/rss/articles/CBMi-gFBVV95cUxNblBPMWpYN0NLR2FlZjY0cjZnRVo4aDNPUnFyMDNhWEZIWUstalV0ZEYzQTJaNnk3RVVHWWYxQkhwS1EzUVF2MXMtVHY2dEtOQkVObDhwX0t4eDJQdlpCQTE2dGRKQ2lyLUozVG45dUc1QlNPTXpiR0sxWnZiVm9xbUpDXzV3d1RUanp2YWF6MWg2UVVIMEVzaThqa2M4dXZMYW5GaW0yM3pwVlNHZUNwQW1oRVc1b3AtOEtKdzlRYXRTQ2pkMTZuY045OFNGNm01MG8xdW1zLVlzZ3FWeTFfN3hDTGlfa051WGYtWHdubTBWM1VrYnN0VjBn?oc=5" target="_blank">Timepoint at which developing B-cells become cancerous impacts leukemia treatment</a>&nbsp;&nbsp;<font color="#6f6f6f">St. Jude Children's Research Hospital</font>
<a href="https://news.google.com/rss/articles/CBMikgFBVV95cUxPaUQ1bVE0SFc1bUdlRzFDV3F6V001SFpoWFh3LUw0bjFVU2pfWTlWYk1mcHlVUmdWOG0tdVVlR1lPRjRvNG5menRuT1JzRFE0RFpMSlVtUWhzTE95LWl2VXZBRkRLS3ZSbElRNFoxNFBsOXZqVlhLWjVmemhwWkRiSThwbUVJZEdwRFhoSER5bXFqdw?oc=5" target="_blank">Potential of small-molecule targeted drugs in combination with CAR-T cell therapy for hematologic lymphomas</a>&nbsp;&nbsp;<font color="#6f6f6f">Frontiers</font>